Cryptococcus infection medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cryptococcus infection}} {{CMG}}; {{AE}} ==Overview== ==References== {{Reflist|2}}" |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | |||
===Antimicrobial Regimen=== | |||
*'''Cryptococcus Meningoencephalitis in Human Immunodeficiency Virus–Infected Individuals''' | |||
**'''Induction Therapy''' | |||
::*Preferred regimen (1): Amphotericin B deoxycholate (0.7–1.0 mg/kg per day) plus flucytosine (100 mg/kg per day) for 2 weeks {{AND}} Begin HAART 2–10 weeks after the start of initial antifungal treatment. | |||
::*Preferred regimen (2): Liposomal AmB (3–4 mg/kg per day) or ABLC (5 mg/kg per day, with renal function concerns) plus flucytosine (100 mg/kg per day) for 2 weeks {{AND}} Begin HAART 2–10 weeks after the start of initial antifungal treatment. | |||
::*Preferred regimen (3): AmBd (0.7–1.0 mg/kg per day) or liposomal AmB (3–4 mg/kg per day) or ABLC (5 mg/kg per day, for flucytosine-intolerant patients) | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 15:27, 1 June 2017
|
Cryptococcus infection Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptococcus infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Cryptococcus infection medical therapy |
|
Risk calculators and risk factors for Cryptococcus infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Medical Therapy
Antimicrobial Regimen
- Cryptococcus Meningoencephalitis in Human Immunodeficiency Virus–Infected Individuals
- Induction Therapy
- Preferred regimen (1): Amphotericin B deoxycholate (0.7–1.0 mg/kg per day) plus flucytosine (100 mg/kg per day) for 2 weeks Template:AND Begin HAART 2–10 weeks after the start of initial antifungal treatment.
- Preferred regimen (2): Liposomal AmB (3–4 mg/kg per day) or ABLC (5 mg/kg per day, with renal function concerns) plus flucytosine (100 mg/kg per day) for 2 weeks Template:AND Begin HAART 2–10 weeks after the start of initial antifungal treatment.
- Preferred regimen (3): AmBd (0.7–1.0 mg/kg per day) or liposomal AmB (3–4 mg/kg per day) or ABLC (5 mg/kg per day, for flucytosine-intolerant patients)